Allergan Botox Settlement Totals $600 Million
New York Times:
Allergan, the maker of Botox, agreed on Wednesday to pay $600 million to settle charges that it illegally promoted and sold the drug through 2005 for unapproved uses like treating headaches.
Read the whole story: New York Times

First Posted: 9/2/10 Updated: 5/25/11